Related Experiment Videos
[Use of cefoperazone in clinical practice]
Summary
Cefoperazone demonstrated high efficacy and minimal side effects in treating 45 patients with purulent inflammatory diseases, including infections of the abdomen, respiratory, urinary, eye, and soft tissues. This antibiotic is recommended for various purulent conditions and empirical therapy.
Area of Science:
- Infectious Diseases
- Clinical Pharmacology
- Bacteriology
Background:
- Purulent inflammatory diseases pose significant therapeutic challenges.
- Effective antibiotic options are crucial for managing severe and moderate infections.
- Cefoperazone is a cephalosporin antibiotic with a broad spectrum of activity.
Purpose of the Study:
- To evaluate the bacteriological and clinical efficacy of cefoperazone.
- To assess the side effect profile of cefoperazone in patients with purulent inflammatory diseases.
- To determine the suitability of cefoperazone for empirical therapy.
Main Methods:
- A study involving 45 patients with severe and moderate purulent inflammatory diseases.
- Assessment of bacteriological eradication and clinical improvement.
- Monitoring and documentation of adverse events.
Main Results:
- High bacteriological and clinical efficacy observed across various infection sites, including peritonitis, cholecystitis, respiratory, urinary, ocular, and soft tissue infections.
- Overall clinical efficacy reached 95.6%.
- The incidence of side effects associated with cefoperazone was insignificant.
Conclusions:
- Cefoperazone is a highly effective antibiotic for treating a wide range of purulent inflammatory diseases.
- The favorable efficacy and safety profile support the use of cefoperazone in clinical practice.
- Cefoperazone is a viable option for empirical treatment of purulent infections.